Log In
Print
BCIQ
Print
Print this Print this
 

Cordaptive, Pelzont, Tredaptive, Trevaclyn (MK-0524A)

Also known as: ER niacin/laropiprant

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionCombination of laropiprant, a selective inhibitor of prostaglandin D2 (PGD2) receptor (CRTH2; GPR44) subtype DP1, and extended-release niacin
Molecular Target Prostaglandin D2 (PGD2) receptor subtype DP1 (PTGDR1) (DP1)
Mechanism of ActionProstaglandin D2 (PGD2) receptor subtype DP2 (CRTH2) antagonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today